Paul E. Wiedeman
Impact in
- Sensory Systems top 5%
- Ion Channels and Receptors
- Toxicology top 5%
Papers in
-
- Veterinary medicine and infectious diseases 5
-
- Diabetes Treatment and Management 7
- Co-authors
- James M. Trevillyan (5 shared papers)Leo A. Paquette (5 shared papers)Stevan W. Djurić (5 shared papers)Philip C. Bulman Page (3 shared papers)Paul D. Pansegrau (2 shared papers)Marina A. Pliushchev (2 shared papers)Richard J. Sciotti (2 shared papers)Stephen J. Ballaron (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Tetrahedron Letters (4 papers)The Journal of Organic Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)The FASEB Journal (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Paul E. Wiedeman
25 papers receiving 666 citations
Peers
Comparison fields: 5 of 72
- Sensory Systems 73
- Toxicology 39
- Organic Chemistry 280
- Pharmaceutical Science 52
- Endocrinology, Diabetes and Metabolism 98
Countries citing papers authored by Paul E. Wiedeman
This map shows the geographic impact of Paul E. Wiedeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Wiedeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Wiedeman more than expected).
Fields of papers citing papers by Paul E. Wiedeman
This network shows the impact of papers produced by Paul E. Wiedeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Wiedeman. The network helps show where Paul E. Wiedeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul E. Wiedeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 105 | |
| 2 | 2001 | 88 | |
| 3 | Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes. | 2003 | 53 |
| 4 | 2002 | 52 | |
| 5 | 2006 | 52 | |
| 6 | 2001 | 41 | |
| 7 | 2006 | 38 | |
| 8 | 1999 | 35 | |
| 9 | 2006 | 33 | |
| 10 | 1988 | 28 | |
| 11 | 1988 | 25 | |
| 12 | 2007 | 24 | |
| 13 | 2005 | 23 | |
| 14 | 1998 | 21 | |
| 15 | 2006 | 18 | |
| 16 | 1988 | 18 | |
| 17 | 1985 | 14 | |
| 18 | 2008 | 13 | |
| 19 | 1999 | 6 | |
| 20 | 1985 | 6 |
About Paul E. Wiedeman
Paul E. Wiedeman is a scholar working on Small Animals, Endocrinology, Diabetes and Metabolism, Oncology, Toxicology and Immunology, having authored 25 papers that have together received 706 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Diabetes Treatment and Management (7 papers), Veterinary medicine and infectious diseases (5 papers), Toxin Mechanisms and Immunotoxins (4 papers), Signaling Pathways in Disease (4 papers), Neuropeptides and Animal Physiology (4 papers), Pancreatic function and diabetes (3 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Sensory Systems (73 citations), Toxicology (39 citations), Organic Chemistry (280 citations), Pharmaceutical Science (52 citations) and Endocrinology, Diabetes and Metabolism (98 citations). Paul E. Wiedeman has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include James M. Trevillyan, Leo A. Paquette, Stevan W. Djurić, Philip C. Bulman Page, Paul D. Pansegrau, Marina A. Pliushchev, Richard J. Sciotti, Stephen J. Ballaron, David J. Madar and Vince S. C. Yeh. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters, The Journal of Organic Chemistry, Bioorganic & Medicinal Chemistry Letters and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.